Bard Associates Inc. cut its stake in shares of The Joint Corp. (NASDAQ:JYNT – Free Report) by 12.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 73,275 shares of the company’s stock after selling 10,775 shares during the period. Bard Associates Inc. owned 0.49% of Joint worth $779,000 as of its most recent filing with the SEC.
Other hedge funds also recently made changes to their positions in the company. FMR LLC lifted its position in shares of Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company’s stock valued at $123,000 after buying an additional 2,971 shares during the last quarter. Franklin Resources Inc. acquired a new stake in shares of Joint in the third quarter valued at approximately $175,000. Sanders Morris Harris LLC acquired a new stake in shares of Joint in the fourth quarter valued at approximately $228,000. BNP Paribas Financial Markets lifted its position in shares of Joint by 5.4% in the third quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock valued at $258,000 after buying an additional 1,156 shares during the last quarter. Finally, Barclays PLC lifted its position in shares of Joint by 71.4% in the third quarter. Barclays PLC now owns 25,609 shares of the company’s stock valued at $294,000 after buying an additional 10,671 shares during the last quarter. 76.88% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
JYNT has been the subject of a number of recent analyst reports. StockNews.com raised Joint from a “hold” rating to a “buy” rating in a research report on Friday, November 15th. Roth Mkm lowered their target price on Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, November 8th.
Joint Trading Down 2.0 %
Shares of NASDAQ JYNT opened at $11.12 on Tuesday. The firm has a market cap of $166.62 million, a P/E ratio of -9.75 and a beta of 1.60. The Joint Corp. has a 1-year low of $9.10 and a 1-year high of $17.82. The business’s 50 day moving average is $10.98 and its 200-day moving average is $11.18.
Joint Profile
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Further Reading
- Five stocks we like better than Joint
- Investing in Construction Stocks
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Best Aerospace Stocks Investing
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.